- Home
- LVLU vs IXHL Comparison
LVLU vs IXHL Comparison
Compare LVLU & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LVLU | IXHL |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.6M | 45.0M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | LVLU | IXHL |
|---|---|---|
| Price | $10.10 | $4.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 458.4K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $282,284,000.00 | $12,000.00 |
| Revenue This Year | $5.66 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.22 | $0.11 |
| 52 Week High | $32.32 | $6.39 |
Technical Indicators
Market Signals| Indicator | LVLU | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 68.84 |
| Support Level | $3.87 | $0.34 |
| Resistance Level | $12.76 | $5.17 |
| Average True Range (ATR) | 1.03 | 0.35 |
| MACD | 0.26 | 0.06 |
| Stochastic Oscillator | 33.52 | 89.79 |
Price Performance
Historical ComparisonAbout LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.